CoChat

Identification of Highly Conserved Residues Involved in Inhibition of HIV-1 RNase H Function by Diketo Acid Derivatives

Open access
Corona, Angela, Di Leva, Francesco Saverio, Thierry, Sylvain, Pescatori, Luca, Cuzzucoli Crucitti, Giuliana, Subra, Frederic, Delelis, Olivier, Esposito, Francesca, Rigogliuso, Giuseppe, Costi, Roberta, Cosconati, Sandro, Novellino, Ettore, Di Santo, Roberto, Tramontano, Enzo · 2014 · Antimicrobial Agents and Chemotherapy
Cited by 68

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

HIV-1 reverse transcriptase (RT)-associated RNase H activity is an essential function in viral genome retrotranscription. RNase H is a promising drug target for which no inhibitor is available for therapy. Diketo acid (DKA) derivatives are active site Mg 2+ -binding inhibitors of both HIV-1 RNase H and integrase (IN) activities. To investigate the DKA binding site of RNase H and the mechanism of action, six couples of ester and acid DKAs, derived from 6-[1-(4-fluorophenyl)methyl-1 H -pyrrol-2-yl)]-2,4-dioxo-5-hexenoic acid ethyl ester (RDS1643), were synthesized and tested on both RNase H and IN functions. Most of the ester derivatives showed selectivity for HIV-1 RNase H versus IN, while acids inhibited both functions. Molecular modeling and site-directed mutagenesis studies on the RNase H domain demonstrated different binding poses for ester and acid DKAs and proved that DKAs interact with residues (R448, N474, Q475, Y501, and R557) involved not in the catalytic motif but in highly conserved portions of the RNase H primer grip motif. The ester derivative RDS1759 selectively inhibited RNase H activity and viral replication in the low micromolar range, making contacts with residues Q475, N474, and Y501. Quantitative PCR studies and fluorescence-activated cell sorting (FACS) analyses showed that RDS1759 selectively inhibited reverse transcription in cell-based assays. Overall, we provide the first demonstration that RNase H inhibition by DKAs is due not only to their chelating properties but also to specific interactions with highly conserved amino acid residues in the RNase H domain, leading to effective targeting of HIV retrotranscription in cells and hence offering important insights for the rational design of RNase H inhibitors.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1128/aac.03605-14

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Research works printed but not linked: 45

  1. 10.1155/2012/586401 · DOI
  2. 10.1128/JVI.02524-09 · DOI
  3. 10.1128/AAC.00591-12 · DOI
  4. 10.2165/11633630-000000000-00000 · DOI · Paper page
  5. SchatzOCrommeFVNaasTLindemannDMousJLe GriceSFJ. 1990. Inactivation of the RNase H domain of HIV-1 reverse transcriptase blocks viral infectivity, p 293–404. In PapasT (ed), Gene regulation and AIDS. Portfolio, Houston, TX.
  6. 10.2174/138955706777435733 · DOI
  7. 10.2174/092986710792065045 · DOI · Paper page
  8. 10.1093/nar/gkg881 · DOI · Paper page
  9. 10.1093/nar/gki268 · DOI · Paper page
  10. 10.1021/jm900597q · DOI · Paper page
  11. 10.1128/JVI.00353-10 · DOI · Paper page
  12. 10.1021/jm801071m · DOI
  13. 10.1016/j.bmcl.2012.04.096 · DOI
  14. 10.1016/j.bmcl.2009.10.043 · DOI
  15. 10.1128/AAC.00434-10 · DOI · Paper page
  16. 10.1021/jm400405z · DOI
  17. 10.1021/cb600303y · DOI · Paper page
  18. 10.1111/j.1742-4658.2011.08057.x · DOI · Paper page
  19. 10.1074/jbc.M111.314781 · DOI · Paper page
  20. 10.2174/1381612811319100009 · DOI · Paper page
  21. 10.1002/cmdc.201402015 · DOI
  22. RauschJW. 2013. Ribonuclease H inhibitors: structural and molecular biology, p 143–172. In Le GriceSFJGotteM (ed), Human immunodeficiency virus reverse transcriptase: a bench-to-bedside success. Springer, New York, NY. · DOI
  23. 10.2174/138161206776873653 · DOI · Paper page
  24. 10.1128/AAC.38.12.2827 · DOI · Paper page
  25. 10.1021/jm000176b · DOI · Paper page
  26. 10.1016/j.biocel.2004.02.020 · DOI
  27. 10.1016/j.antiviral.2004.11.002 · DOI
  28. 10.1021/jm401040b · DOI
  29. 10.1128/AAC.00056-14 · DOI
  30. 10.1074/jbc.M110.189274 · DOI
  31. 10.1111/2049-632X.12051 · DOI · Paper page
  32. 10.1371/journal.pone.0000608 · DOI
  33. 10.1186/1742-4690-5-60 · DOI · Paper page
  34. 10.1101/cshperspect.a007161 · DOI · Paper page
  35. 10.1021/jm5001503 · DOI · Paper page
  36. 10.1021/ja9621760 · DOI · Paper page
  37. 10.1186/1742-4690-10-87 · DOI
  38. 10.1073/pnas.142123199 · DOI · Paper page
  39. 10.1021/bi015970t · DOI · Paper page
  40. 10.1128/AAC.01075-09 · DOI
  41. 10.1074/jbc.C200621200 · DOI · Paper page
  42. 10.2174/092986710790192695 · DOI
  43. 10.1073/pnas.0409823102 · DOI · Paper page
  44. 10.1128/AAC.01594-10 · DOI · Paper page
  45. 10.1128/JVI.00353-10 · DOI · Paper page

Cited by

See all 68

Metadata

Authors
Corona, A., Di Leva, F. S., Thierry, S., Pescatori, L., Cuzzucoli Crucitti, G., Subra, F., Delelis, O., Esposito, F., Rigogliuso, G., Costi, R., Cosconati, S., Novellino, E., Di Santo, R., & Tramontano, E.
Venue
Antimicrobial Agents and Chemotherapy
Published
2014-10
Volume
58
Issue
10
Pages
6101-6110
ISSN
  • 0066-4804 (ISSN-L)
  • 1098-6596
OpenAlex
W2135341254
Cited by
68
References
3
FWCI
6.06
Type
journal article
Language
en
Open access
bronze
Licence
journals.asm.org/non-commercial-tdm-license (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Identification of Highly Conserved Residues Involved in Inhibition of HIV-1 RNase H Function by Diketo Acid Derivatives. https://app.cochat.ai/papers/10.1128/aac.03605-14
The paper
Corona, A., Di Leva, F. S., Thierry, S., Pescatori, L., Cuzzucoli Crucitti, G., Subra, F., Delelis, O., Esposito, F., Rigogliuso, G., Costi, R., Cosconati, S., Novellino, E., Di Santo, R., & Tramontano, E. (2014). Identification of Highly Conserved Residues Involved in Inhibition of HIV-1 RNase H Function by Diketo Acid Derivatives. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.03605-14

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.